GlassScriptPhysician profile
Samip Jayantilal Borad
NPI 1033353081
$5,006.72
in general payments reported to CMS, 2019-2025
32 companies · $1,832 in 2025
The $1,832 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,329 · 2020: $252 · 2021: $250 · 2022: $322 · 2023: $22.20 · 2025: $1,832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,837 · Education: $17.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,836.53 |
| Education | $17.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,594.23 | 2019 | |
| Abbvie INC. | $592.70 | 2021-2025 | Duopa |
| Pfizer INC. | $408.13 | 2019-2025 | |
| Amgen INC. | $251.92 | 2019-2025 | Uplizna |
| Novartis Pharmaceuticals Corporation | $209.49 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $168.08 | 2025 | Nuplazid |
| Teva Pharmaceuticals USA, INC. | $141.54 | 2019-2025 | Austedo Xr |
| Allergan, INC. | $133.17 | 2020 | |
| Greenwich Biosciences, INC. | $128.32 | 2019 | |
| Ucb, INC. | $120.50 | 2019-2025 | Briviact |
| Biohaven Pharmaceuticals, INC. | $120.32 | 2021 | |
| Eisai INC. | $118.52 | 2019-2025 | |
| Microvention, INC. | $108.41 | 2022 | |
| Alexion Pharmaceuticals, INC. | $101.05 | 2022-2025 | Ultomiris |
| Otsuka America Pharmaceutical, INC. | $98.96 | 2025 | Rexulti |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $87.39 | 2025 | Vyvgart Hytrulo, Vyvgart |
| Ceribell, INC. | $80.00 | 2025 | Pocket Eeg Device |
| Tanabe Pharma America, INC. | $73.29 | 2025 | Radicava |
| Amneal Pharmaceuticals LLC | $68.13 | 2025 | Crexont |
| Janssen Biotech, INC. | $56.52 | 2025 | |
| Life Molecular Imaging LTD | $56.37 | 2025 | Neuraceq |
| Supernus Pharmaceuticals, INC. | $48.94 | 2019-2020 | |
| Aucta Pharmaceuticals, INC. | $41.32 | 2025 | Motpoly Xr |
| Biogen, INC. | $40.82 | 2025 | Leqembi |
| Harmony Biosciences LLC | $27.16 | 2025 | |
| Mdd US Operations, LLC | $23.08 | 2025 | Gocovri |
| Neurocrine Biosciences, INC. | $21.20 | 2025 | |
| Boston Scientific Corporation | $20.29 | 2020 | |
| Janssen Pharmaceuticals, INC | $17.90 | 2025 | |
| Genentech USA, INC. | $17.56 | 2025 | Ocrevus Zunovo |
| Impel Pharmaceuticals LLC | $16.64 | 2025 | Trudhesa |
| Emd Serono, INC. | $14.77 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samip Borad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.